Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

Marshall A. Mazepa, Jay S. Raval, Stephan Moll, Alice Ma, Yara A. Park

Research output: Contribution to journal › Letter › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura'. Together they form a unique fingerprint.